11. Poročilo o preskusu št.: LVG 2024-022 : vzorec št. 2024/00043/THTine Hauptman, Špela Hočevar, Barbara Piškur, 2024, izvedensko mnenje, arbitražna odločba Ključne besede: varstvo gozdov, morfološke analize, Quercus petraea, Fusarium sp., Tolypocladium sp., molekularne analize, javna gozdarska služba
Objavljeno v DiRROS: 23.05.2024; Ogledov: 67; Prenosov: 48
 Celotno besedilo (1,17 MB) |
12. Poročilo o preskusu št.: LVG 2024-021 : vzorec št. 2024/00006/G4Tine Hauptman, Špela Hočevar, Barbara Piškur, 2024, izvedensko mnenje, arbitražna odločba Ključne besede: varstvo gozdov, morfološke analize, Carpinus betulus, Phaeoacremonium fraxinopennsylvanicum, Anisandrus dispar, javna gozdarska služba
Objavljeno v DiRROS: 23.05.2024; Ogledov: 73; Prenosov: 73
Celotno besedilo (1,17 MB)
Gradivo ima več datotek! Več... |
13. |
14. Tuning the long-term corrosion behaviour of biodegradable WE43 magnesium alloy by PEO coatingJulia Nachtsheim, Songyun Ma, Jaka Burja, Barbara Šetina, Bernd Markert, 2023, izvirni znanstveni članek Ključne besede: long-term degradation, in vitro corrosion mechanisms: biodegradable, magnesium, DMEM fluid, hydrogen evolution, PEO coating
Objavljeno v DiRROS: 20.05.2024; Ogledov: 82; Prenosov: 49
 Povezava na datoteko |
15. Poročilo o preskusu št.: LVG 2024-00095 : vzorec št. 12179633Nikica Ogris, Špela Hočevar, Barbara Piškur, 2024, izvedensko mnenje, arbitražna odločba Ključne besede: varstvo gozdov, morfološke analize, platana, Platanus x hispanica, bolezen drevesa, rakasta razjeda, rak, Phomopsis, Diaporthe
Objavljeno v DiRROS: 10.05.2024; Ogledov: 109; Prenosov: 0
Gradivo ima več datotek! Več... |
16. |
17. Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescenceAna Lina Vodušek, Katja Goričar, Barbara Gazić, Vita Dolžan, Janez Jazbec, 2016, izvirni znanstveni članek Povzetek: Background. Thyroid cancer is one of the most common secondary cancers after treatment of malignancy in childhood or adolescence. Thyroid gland is very sensitive to the carcinogenic effect of ionizing radiation, especially in children. Imbalance between pro- and anti-oxidant factors may play a role in thyroid carcinogenesis. Our study aimed to assess the relationship between genetic variability of antioxidant defence-related genes and the risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence. Patients and methods. In a retrospective study, we compared patients with childhood or adolescence primary malignancy between 1960 and 2006 that developed a secondary thyroid cancer (cases) with patients (controls), with the same primary malignancy but did not develop any secondary cancer. They were matched for age, gender, primary diagnosis and treatment (especially radiotherapy) of primary malignancy. They were all genotyped for SOD2 p.Ala16Val, CAT c.-262C>T, GPX1 p.Pro200Leu, GSTP1 p.Ile105Val, GSTP1 p.Ala114Val and GSTM1 and GSTT1 deletions. The influence of polymorphisms on occurrence of secondary cancer was examined by McNemar test and Cox proportional hazards model. Results. Between 1960 and 2006 a total of 2641 patients were diagnosed with primary malignancy before the age of 21 years in Slovenia. Among them 155 developed a secondary cancer, 28 of which were secondary thyroid cancers. No significant differences in the genotype frequency distribution were observed between cases and controls. Additionally we observed no significant influence of investigated polymorphisms on time to the development of secondary thyroid cancer. Conclusions. We observed no association of polymorphisms in antioxidant genes with the risk for secondary thyroid cancer after treatment of malignancy in childhood or adolescence. However, thyroid cancer is one of the most common secondary cancers in patients treated for malignancy in childhood or adolescence and the lifelong follow up of these patients is of utmost importance.
Ključne besede: secondary thyroid cancer, antioxidant genes, genetic polymorphism
Objavljeno v DiRROS: 09.05.2024; Ogledov: 105; Prenosov: 64
Celotno besedilo (500,53 KB)
Gradivo ima več datotek! Več... |
18. Imaging of human glioblastoma cells and their interactions with mesenchymal stem cells in the zebrafish (Danio rerio) embryonic brainMiloš Vittori, Barbara Breznik, Tajda Gredar, Katja Hrovat, Lilijana Bizjak-Mali, Tamara Lah Turnšek, 2016, izvirni znanstveni članek Ključne besede: brain tumors, tumor microenvironment, animal models, xenotransplantation
Objavljeno v DiRROS: 09.05.2024; Ogledov: 105; Prenosov: 410
Celotno besedilo (1,35 MB) |
19. Virtual modelling of novel applicator prototypes for cervical cancer brachytherapyPrimož Petrič, Robert Hudej, Noora Al-Hammadi, Barbara Šegedin, 2016, izvirni znanstveni članek Povzetek: Standard applicators for cervical cancer Brachytherapy (BT) do not always achieve acceptable balance between target volume and normal tissue irradiation. We aimed to develop an innovative method of Targetvolume Density Mapping (TDM) for modelling of novel applicator prototypes with optimal coverage characteristics. Patients and methods. Development of Contour-Analysis Tool 2 (CAT-2) software for TDM generation was the core priority of our task group. Main requests regarding software functionalities were formulated and guided the coding process. Software validation and accuracy check was performed using phantom objects. Concepts and terms for standardized workflow of TDM post-processing and applicator development were introduced. Results. CAT-2 enables applicator-based co-registration of Digital Imaging and Communications in Medicine (DICOM) structures from a sample of cases, generating a TDM with pooled contours in applicator-eye-view. Each TDM voxel is assigned a value, corresponding to the number of target contours encompassing that voxel. Values are converted to grey levels and transformed to DICOM image, which is transported to the treatment planning system. Iso-density contours (IDC) are generated as lines, connecting voxels with same grey levels. Residual Volume at Risk (RVR) is created for each IDC as potential volume that could contain organs at risk. Finally, standard and prototype applicators are applied on the TDM and virtual dose planning is performed. Dose volume histogram (DVH) parameters are recorded for individual IDC and RVR delineations and characteristic curves generated. Optimal applicator configuration is determined in an iterative manner based on comparison of characteristic curves, virtual implant complexities and isodose distributions. Conclusions. Using the TDM approach, virtual applicator prototypes capable of conformal coverage of any target volume, can be modelled. Further systematic assessment, including studies on clinical feasibility, safety and effectiveness are needed before routine use of novel prototypes can be considered.
Ključne besede: cervical cancer, brachytherapy, applicators, virtual modelling
Objavljeno v DiRROS: 09.05.2024; Ogledov: 95; Prenosov: 38
Celotno besedilo (671,88 KB) |
20. Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myelomaDirk Rades, Antonio J. Conde-Moreno, Jon Cacicedo, Barbara Šegedin, Volker Rudat, Steven E. Schild, 2016, izvirni znanstveni članek Povzetek: Uncertainty exists whether patients with spinal cord compression (SCC) from a highly radiosensitive tumor require decompressive spinal surgery in addition to radiotherapy (RT). This study addressed the question by evaluating patients receiving RT alone for SCC from myeloma. Patients and methods. Data of 238 patients were retrospectively analyzed for response to RT and local control of SCC. In addition, the effect of RT on motor function (improvement, no further progression, deterioration) was evaluated. Overall response was defined as improvement or no further progression of motor dysfunction. Prior to RT, patients were presented to a neurosurgeon for evaluation whether upfront decompressive surgery was indicated (e.g. vertebral fracture or unstable spine). Results. In the entire cohort, the overall response rate was 97% (53% improvement plus 44% no further progression). Following RT, 88% of the patients were able to walk. Of the 69 non-ambulatory patients 44 patients (64%) regained the ability to walk. Local control rates at 1, 2 and 3 years were 93%, 82% and 82%, respectively. A trend towards better local control was observed for patients who were ambulatory before starting RT (p = 0.08) and those with a more favorable performance status (p = 0.07). Conclusions. RT alone provided excellent response rates, functional outcomes and local control in patients with SCC from myeloma. These results should be confirmed in a prospective randomized trial.
Ključne besede: myeloma, spinal cord compression, radiotherapy
Objavljeno v DiRROS: 30.04.2024; Ogledov: 190; Prenosov: 85
Celotno besedilo (585,22 KB)
Gradivo ima več datotek! Več... |
